Potentiation of ricin cytotoxicity by liposomal monensin under in vitro and in vivo conditions.
Effect of monensin, intercalated in liposomes on the cytotoxicities of ricin, Pseudomonas exotoxin A and diphtheria toxin in phagocytic and non-phagocytic cells as well as in mice has been studied. Intercalation does not disturb the integrity of the liposomal bilayer and substantially enhances the cytotoxicities of ricin and Pseudomonas exotoxin A in both phagocytic and non-phagocytic cells while it has no effect on diphtheria toxin. The observed effect is highly dependent on the liposomal lipid composition as well as cell types. The potentiating ability of monensin in neutral vesicle is 2.2-fold higher than in negatively charged vesicles in non-phagocytic cells while no difference was observed in phagocytic cells. Incorporation of stearylamine in liposomes reduces the potentiating effect of monensin. Liposomal monensin has also been found to enhance the cytotoxicity of ricin in mouse in vivo in a dose-dependent manner and is maximal when ricin is injected within 60 min of monensin injection. Liposomal monensin remains in circulation for 2 hr while free monensin remains only for 15 min. Tissue distribution studies reveal that liposomal monensin is present mainly in the liver and spleen which are also the major sites for ricin accumulation. Thus liposome is found to be an effective delivery vehicle for monensin to potentiate the cytotoxicity of immunotoxins or hormonotoxins and could prove useful for selective elimination of cancer cells.
Madan
S
S
Department of Biochemistry, University of Delhi, India.
Vasandani
V M
VM
Ghosh
P C
PC
D036002:ADP Ribose Transferases; D000818:Animals; D001427:Bacterial Toxins; D016466:CHO Cells; D002470:Cell Survival / Q000187:drug effects*; D006224:Cricetinae; D004167:Diphtheria Toxin / Q000633:toxicity; D004337:Drug Carriers; D004357:Drug Synergism; D005098:Exotoxins / Q000633:toxicity; D008051:Lipid Bilayers; D008264:Macrophages / Q000166:cytology / Q000187:drug effects; D051379:Mice; D008985:Monensin / Q000008:administration & dosage / Q000633:toxicity*; D010587:Phagocytosis; D011550:Pseudomonas aeruginosa; D012276:Ricin / Q000633:toxicity*; D037521:Virulence Factors; D000097668:Pseudomonas aeruginosa Exotoxin A
D036002:ADP Ribose Transferases; D001427:Bacterial Toxins; D004167:Diphtheria Toxin; D004337:Drug Carriers; D005098:Exotoxins; D008051:Lipid Bilayers; D008985:Monensin; D012276:Ricin; D037521:Virulence Factors; D000097668:Pseudomonas aeruginosa Exotoxin A